Advertisement

Topics

MabThera, Enbrel biosimilars from Sandoz introduced in UK

06:16 EDT 30 Jun 2017 | SmartBrief

Sandoz's Rixathon, a biosimilar to MabThera, or rituximab, has been launched in the UK as a treatment for patients with folli -More

Original Article: MabThera, Enbrel biosimilars from Sandoz introduced in UK

NEXT ARTICLE

More From BioPortfolio on "MabThera, Enbrel biosimilars from Sandoz introduced in UK"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...